Natural Beauty Bio-Technology Limited provided unaudited consolidated earnings guidance for the six months ended 30 June 2022. For the six months ended 30 June 2022, the Group is expected to record a net loss of approximately HKD 23.6 million for the six months ended 30 June 2022, representing a significant decline by approximately 239% as compared with the net profits of approximately HKD 17.0 million for the six months ended 30 June 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.53 HKD | +6.00% | +3.92% | +10.42% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+10.42% | 128M | |
-0.68% | 264B | |
+19.72% | 20.89B | |
0.00% | 19.67B | |
+15.62% | 12.52B | |
-14.17% | 9.53B | |
+19.93% | 8.03B | |
+10.20% | 6.01B | |
-2.43% | 4.49B | |
-13.55% | 4.01B |
- Stock Market
- Equities
- 157 Stock
- News Natural Beauty Bio-Technology Limited
- Natural Beauty Bio-Technology Limited Provides Unaudited Consolidated Earnings Guidance for the Six Months Ended 30 June 2022